Paris, France will host BIO-Europe Spring® 2015 international life science partnering conference

The ninth annual BIO-Europe Spring® conference will be held March 9–11, 2015 in Paris, France at the Paris expo Porte de Versailles conference center. This is the first time Paris will host a life science industry event of this scale, and it is expected to draw a large number of established biotech and early stage companies desiring to form business partnerships with investors and big pharma companies.

Pharmaceutical giant Sanofi is a major sponsor of the event, as well as Laboratoires Servier and Sofinnova Ventures. The event is the largest springtime life science partnering conference. The event brings investor and pharma partners together with life science companies to forge deals that ultimately transform the healthcare market.


The one-to-one meetings that take place at BIO-Europe Spring between potential partners have broad ranging benefits for the drug development pipeline. These meetings are an effective business strategy enabling life science companies to meet and present to numerous potential partners. The program is also geared toward partnerships, where industry thought leaders speak on topics ranging from tough issues faced by drug developers, to regulatory hurdles to funding and commercialization strategies.


“Paris is an ideal location for BIO-Europe Spring,” said Anna Chrisman, Group Managing Director, EBD Group. “Paris is one of the largest life science clusters in Europe, well-known for its culture of excellence, from basic research and discovery at the universities all the way to drug development for major diseases.”


The Paris region brings together seven innovation clusters enhancing life science innovation. The number one region for developing startups in Western Europe, Paris is also a leader in oncology, neurosciences, infectious diseases and cardiology research and therapy with prestigious institutions such as the Curie Institute, the Gustave Roussy (the number one center in Europe for early stage cancer therapies), the Brain and Spine Institute, and the Pasteur Institute ( the leading microbiology research center in Europe) to name just a few. Over 1,000 life science companies are located in the Paris Region, and over 500 international companies have a base in Paris.


“It speaks to the growth of the Paris region as a bio innovation hub that BIO-Europe Spring, a world-class industry event, is coming to Paris in March,” said Jean-Roch Meunier, CEO of Medicen Paris Region. “Paris is a leading center for disease research and health technologies, with an environment ripe with partnering opportunities.”


“We are very excited to host BIO-Europe Spring 2015 in Paris, as we are an extremely active cluster and have many partnerships with companies in Europe, America and Asia,” said Nathalie Desnoyer, International Life Sciences Director from the Paris Region Economic Development Agency. “It makes sense to bring them all together in March to discover what’s new in Paris and the many international business opportunities for collaboration.”


In 2014, BIO-Europe Spring was held in Turin, Italy, where over 2,000 attendees from 1,209 companies participated in 10,780 one-to-one meetings involving 2,115 licensing opportunities. BIO-Europe Spring will continue to provide life science companies with high caliber partnering opportunities in Paris, France.


Register before January 20, 2015, and save EUR 200 off the regular registration fee.


At BIO-Europe Spring, companies participate in one-to-one partnering meeting facilitated by EBD Group’s highly reputable partneringONE® platform. partneringONE is EBD Group’s sophisticated, web-based partnering system that enables event delegates to efficiently identify, meet and get partnerships started with companies across the life science value chain, from large biotech and pharma companies to financiers and innovative startups.


About BIO-Europe Spring® 2015:

As the springtime counterpart to BIO-Europe®, BIO-Europe Spring® continues the tradition of providing life science companies with high caliber partnering opportunities. Featuring EBD Group’s acclaimed partnering system, partneringONE®, the event enables delegates to efficiently identify, meet and get partnerships started with companies across the biotech value chain.

In addition to productive partnering, BIO-Europe Spring offers high level workshops, panels, company presentations, and a lively exhibition. The program features executive level panelists who openly share their insight and opinion on many important industry issues. The company presentation tracks provide a forum for innovative startups, established biotech companies, and large and midsize pharma to present information on products, partnering opportunities and corporate strategy.

Combined, these elements create an insightful and productive event that will have you coming back year after year.

BIO-Europe Spring is produced by EBD Group, the leading partnering firm for the global biotechnology industry, with the support of the Biotechnology Industry Organization (BIO).


Follow BIO-Europe Spring 2015 on Twitter: (hashtag: #BES15). Or log on to the BIO-Europe Spring 2015 Discussion Forum on partnering360®. The Group is your go-to discussion forum for news and topics related to BIO-Europe Spring.


About  EBD Group

EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group’s partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.

EBD Group’s conferences are run with the support of leading corporations and international trade associations and include:

  • BIO-Europe® and BIO-Europe Spring®, Europe’s largest life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)
  • BioPharm America™, the fastest growing partnering event in North America
  • Biotech Showcase™, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton Life Science Advisors
  • BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO
  • ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio® LLC
  • Medtech Partnering Forum Japan, EBD Group’s partnering event for the innovative medical technology industry
  • The Global Impact Forum™, a unique and innovative partnering conference in impact investing and venture philanthropy.


EBD Group’s sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world, and partnering360® is the open online community of life science dealmakers that enhances partnering experiences throughout the year.

EBD Group is an Informa company. Informa is the largest publicly-owned organizer of exhibitions, conferences and training in the world.

EBD Group has offices in the USA and Europe.

For more information please visit


Erin Righetti

EBD Group

+1 760 930 0500